'Designer baby' rules up for debate (UK)
By BBC News,
BBC News
| 07. 17. 2004
The Human Fertilisation and Embryology Authority (HFEA) is to debate its policy on creating babies who can help sick siblings.
It will consider a doctor's request to select an embryo for a Northern Ireland couple that is a blood match with their son, who has a rare blood disorder.
Currently embryos can only be screened for serious genetic disorders.
Dr Mohamed Taranissi, the director of London's Assisted Reproduction Gynaecology Centre, is pursuing a rule change in a bid to help two-year-old Joshua Fletcher, from Moira, County Down.
Joshua has a potentially fatal blood disorder called Diamond Blackfan anaemia (DBA), which can be treated by using stem cells to stimulate his body to produce healthy red blood cells.
| |
We only want to give our son the best chance for a cure for a condition which could take his life
Joe Fletcher
Father of baby Joshua |
Neither his parents, Joe and Julie, nor his five-year-old brother Adam are close enough matches to give him the stem cells he needs.
But IVF technology...
Related Articles
By Samuelle Fajutrao Falk , The Conversation | 06.26.2026
When my colleagues and I asked autistic people and parents of autistic children in Sweden how they feel about genetic research in autism, one response stood out: “I hope genetic research finds new ways to help us, not erase us.”...
By Rebecca Simkin, BioNews | 06.29.2026
The US Food and Drug Administration (FDA) is allowing biotech company Regenxbio to reapply for licensing of a gene therapy for Hunter syndrome, in a reversal of its previous decision. Hunter syndrome, or mucopolysaccharidosis type II (MPS II), is a...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Paul Knoepfler, Stat | 06.24.2026
What if you could precisely change the genome of a pre-implantation human embryo and then safely use that embryo to try to generate a healthier person? It’s a wild idea, but one that technology over the past decade has steadily...
